{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:02:06Z","timestamp":1792728126329,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jaci.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T15:37:59Z","timestamp":1685720279000},"page":"656-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Single-cell transcriptomics suggest distinct upstream drivers of IL-17A\/F in hidradenitis versus psoriasis"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-1425","authenticated-orcid":false,"given":"Jaehwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongmi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasuma","family":"Chaparala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.05.012_bib1","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/exd.14273","article-title":"Histologic progression of acne inversa\/hidradenitis suppurativa: implications for\u00a0future investigations and therapeutic intervention","volume":"30","author":"Dunstan","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13555-020-00391-x","article-title":"Office-based surgical intervention for hidradenitis suppurativa (HS): a focused review for dermatologists","volume":"10","author":"Saylor","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2023.05.012_bib3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.05.012_bib4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jamadermatol.2021.2905","article-title":"Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind, placebo-controlled randomized clinical trial","volume":"157","author":"Glatt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jaad.2021.07.035","article-title":"The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris","volume":"86","author":"Navrazhina","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaad.2020.05.007","article-title":"The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: an open-label cohort study","volume":"83","author":"Frew","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jaad.2020.02.005","article-title":"Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: results of an open-label trial","volume":"82","author":"Casseres","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF therapy","volume":"137","author":"Moran","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction","volume":"139","author":"Witte-H\u00e4ndel","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib10","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jid.2020.01.023","article-title":"Lesional inflammatory profile in hidradenitis suppurativa is not solely driven by IL-1","volume":"140","author":"Vossen","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139932","article-title":"Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-\u03b1 therapy","volume":"5","author":"Lowe","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2023.05.012_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.665873","article-title":"Single-cell RNA sequencing reveals cellular and transcriptional changes associated with M1 macrophage polarization in hidradenitis suppurativa","volume":"8","author":"Mariottoni","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jaci.2023.05.012_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139930","article-title":"Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis","volume":"5","author":"Gudjonsson","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40257-019-00439-5","article-title":"Biologic treatment for hidradenitis suppurativa","volume":"20","author":"Flood","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-042915-103905","article-title":"Highly effective new treatments for psoriasis target the IL-23\/type 17 T cell autoimmune axis","volume":"68","author":"Kim","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2023.05.012_bib16","author":"East"},{"key":"10.1016\/j.jaci.2023.05.012_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.04.021","article-title":"Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic vs regulatory immune cell subsets","author":"Kim","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.012_bib18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jaci.2021.09.022","article-title":"The editors\u2019 choice","volume":"148","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.012_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2023.05.012_bib20","doi-asserted-by":"crossref","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM III, et\u00a0al. Comprehensive integration of single-cell data. Cell 2019.","DOI":"10.1101\/460147"},{"key":"10.1016\/j.jaci.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17\u2013producing cells originate from a CD161+CD4+ T cell precursor","volume":"205","author":"Cosmi","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2023.05.012_bib22","doi-asserted-by":"crossref","first-page":"279ra39","DOI":"10.1126\/scitranslmed.3010302","article-title":"Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells","volume":"7","author":"Watanabe","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2023.05.012_bib23","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/bjd.15458","article-title":"Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa","volume":"177","author":"Thomi","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib24","first-page":"865","article-title":"IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells","volume":"20","author":"Kempuraj","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.20061405","article-title":"CCR7 is required for the in\u00a0vivo function of CD4+CD25+ regulatory T cells","volume":"204","author":"Schneider","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2023.05.012_bib27","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/s41467-021-22450-3","article-title":"Interleukin-11\u2013expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer","volume":"12","author":"Nishina","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2023.05.012_bib29","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.3390\/ijms23168900","article-title":"IL11 stimulates IL33 expression and proinflammatory fibroblast activation across tissues","volume":"23","author":"Widjaja","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human colon during ulcerative colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2023.05.012_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00717-5","article-title":"Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non\u2013small cell lung cancer","volume":"11","author":"Yamato","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"21469","DOI":"10.1073\/pnas.2009119117","article-title":"A specialized population of Periostin-expressing cardiac fibroblasts contributes to postnatal cardiomyocyte maturation and innervation","volume":"117","author":"Hortells","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/jid.2013.500","article-title":"Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1\u03b1\/IL-6 loop","volume":"134","author":"Taniguchi","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjh.12333","article-title":"Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation","volume":"161","author":"Tucci","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2023.05.012_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","article-title":"Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa","volume":"174","author":"Lima","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib37","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/bjd.18556","article-title":"Interleukin 17C is elevated in lesional tissue of hidradenitis suppurativa","volume":"182","author":"Navrazhina","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130522","article-title":"Compartmentalized cytokine responses in hidradenitis suppurativa","volume":"10","author":"Kanni","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2023.05.012_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti\u2013IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2023.05.012_bib42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib43","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1111\/ijd.14596","article-title":"Long-term therapy with anakinra in hidradenitis suppurativa in three patients","volume":"58","author":"Andr\u00e9","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib44","article-title":"A study to evaluate the efficacy, safety and tolerability of bermekimab in patients with hidradenitis suppurativa","year":"2019","journal-title":"Case Med Res"},{"key":"10.1016\/j.jaci.2023.05.012_bib45","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jid.2019.10.024","article-title":"A phase II open-label study of bermekimab in patients with hidradenitis suppurativa shows resolution of inflammatory lesions and pain","volume":"140","author":"Gottlieb","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102763","article-title":"Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases","volume":"20","author":"Cavalli","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2023.05.012_bib47","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/bjd.14371","article-title":"Gene expression profiling\u00a0of skin and blood in hidradenitis suppurativa","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.012_bib49","doi-asserted-by":"crossref","unstructured":"Kimball AB, Prens EP, Passeron T, Maverakis E, Turchin I, Beeck S, et\u00a0al. Efficacy and safety of risankizumab for the treatment of hidradenitis suppurativa: a phase 2, randomized, placebo-controlled trial. Dermatol Ther 2023.","DOI":"10.1007\/s13555-023-00913-3"},{"key":"10.1016\/j.jaci.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2023.05.012_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2450401","article-title":"The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa","volume":"2017","author":"Jim\u00e9nez-Gallo","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaci.2023.05.012_bib52","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24285","article-title":"Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus\u2013related liver inflammation and fibrosis","volume":"53","author":"Moschen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaci.2023.05.012_bib53","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.jaci.2020.12.651","article-title":"Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa","volume":"147","author":"Navrazhina","year":"2021","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923007054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923007054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T23:35:11Z","timestamp":1724801711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923007054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0091674923007054"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.05.012","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell transcriptomics suggest distinct upstream drivers of IL-17A\/F in hidradenitis versus psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}